Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enteral Nutrition | 8 | 2025 | 104 | 1.870 |
Why?
|
| Child Nutrition Disorders | 3 | 2019 | 13 | 1.780 |
Why?
|
| Nutritional Status | 8 | 2020 | 79 | 1.440 |
Why?
|
| Food, Formulated | 4 | 2025 | 25 | 1.320 |
Why?
|
| Malnutrition | 4 | 2018 | 36 | 1.220 |
Why?
|
| Anthropometry | 3 | 2019 | 75 | 1.180 |
Why?
|
| Refeeding Syndrome | 2 | 2019 | 3 | 1.180 |
Why?
|
| Parenteral Nutrition | 6 | 2024 | 64 | 1.160 |
Why?
|
| Nutrition Assessment | 3 | 2019 | 21 | 1.150 |
Why?
|
| Micronutrients | 3 | 2019 | 18 | 1.010 |
Why?
|
| Trace Elements | 3 | 2019 | 11 | 1.000 |
Why?
|
| Infant | 18 | 2024 | 3220 | 0.980 |
Why?
|
| Infant, Premature | 3 | 2024 | 297 | 0.960 |
Why?
|
| Child | 27 | 2025 | 7355 | 0.910 |
Why?
|
| Child, Preschool | 18 | 2025 | 3829 | 0.890 |
Why?
|
| Gastroenterology | 3 | 2020 | 157 | 0.830 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2023 | 82 | 0.760 |
Why?
|
| Short Bowel Syndrome | 4 | 2017 | 37 | 0.760 |
Why?
|
| Cronobacter | 1 | 2022 | 1 | 0.740 |
Why?
|
| Cronobacter sakazakii | 1 | 2022 | 2 | 0.740 |
Why?
|
| Child Development | 3 | 2019 | 166 | 0.720 |
Why?
|
| Hypophosphatemia | 2 | 2019 | 7 | 0.710 |
Why?
|
| Selenium | 1 | 2021 | 46 | 0.690 |
Why?
|
| Exocrine Pancreatic Insufficiency | 2 | 2019 | 8 | 0.660 |
Why?
|
| Vitamins | 2 | 2019 | 85 | 0.660 |
Why?
|
| Hyperglycemia | 2 | 2019 | 181 | 0.630 |
Why?
|
| Intestinal Absorption | 3 | 2009 | 125 | 0.610 |
Why?
|
| Fanconi Syndrome | 1 | 2018 | 3 | 0.560 |
Why?
|
| Chromium | 1 | 2017 | 17 | 0.540 |
Why?
|
| Glucose | 2 | 2018 | 692 | 0.540 |
Why?
|
| Arm | 1 | 2018 | 97 | 0.520 |
Why?
|
| Nutritional Support | 2 | 2017 | 20 | 0.520 |
Why?
|
| Growth | 3 | 2001 | 42 | 0.490 |
Why?
|
| Avitaminosis | 2 | 2019 | 5 | 0.460 |
Why?
|
| Humans | 43 | 2025 | 93515 | 0.450 |
Why?
|
| Crohn Disease | 4 | 2022 | 808 | 0.440 |
Why?
|
| Infant, Newborn | 7 | 2024 | 2479 | 0.430 |
Why?
|
| End Stage Liver Disease | 1 | 2013 | 73 | 0.360 |
Why?
|
| Mesalamine | 2 | 2005 | 88 | 0.360 |
Why?
|
| Infant Formula | 3 | 2022 | 18 | 0.340 |
Why?
|
| Failure to Thrive | 2 | 2002 | 17 | 0.340 |
Why?
|
| Diarrhea | 2 | 2018 | 179 | 0.330 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2005 | 249 | 0.320 |
Why?
|
| Choline Deficiency | 1 | 2010 | 4 | 0.320 |
Why?
|
| Choline | 1 | 2010 | 24 | 0.310 |
Why?
|
| Malabsorption Syndromes | 1 | 2009 | 21 | 0.310 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2021 | 50 | 0.310 |
Why?
|
| Digestive System Diseases | 1 | 2009 | 19 | 0.300 |
Why?
|
| Growth Disorders | 2 | 2019 | 66 | 0.300 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2009 | 7 | 0.300 |
Why?
|
| Methylmalonic Acid | 1 | 2009 | 7 | 0.300 |
Why?
|
| Electrolytes | 2 | 2019 | 52 | 0.290 |
Why?
|
| Intestines | 2 | 2009 | 432 | 0.290 |
Why?
|
| Body Composition | 2 | 2018 | 74 | 0.290 |
Why?
|
| Reference Values | 2 | 2019 | 608 | 0.270 |
Why?
|
| Energy Metabolism | 2 | 2019 | 299 | 0.260 |
Why?
|
| Amino Acids | 3 | 2023 | 249 | 0.260 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2009 | 202 | 0.260 |
Why?
|
| Probiotics | 1 | 2008 | 92 | 0.250 |
Why?
|
| Adolescent | 13 | 2018 | 9606 | 0.250 |
Why?
|
| Dietary Fats | 2 | 2019 | 135 | 0.240 |
Why?
|
| Hypervitaminosis A | 1 | 2005 | 2 | 0.230 |
Why?
|
| Vitamin A | 1 | 2005 | 27 | 0.230 |
Why?
|
| Diagnosis, Differential | 5 | 2019 | 1546 | 0.220 |
Why?
|
| Feces | 3 | 2019 | 360 | 0.220 |
Why?
|
| Male | 20 | 2023 | 44557 | 0.220 |
Why?
|
| Rehydration Solutions | 1 | 2004 | 4 | 0.220 |
Why?
|
| Dietary Supplements | 1 | 2005 | 131 | 0.220 |
Why?
|
| Dehydration | 1 | 2004 | 20 | 0.210 |
Why?
|
| Milk | 3 | 2020 | 56 | 0.210 |
Why?
|
| Gastroenteritis | 1 | 2004 | 26 | 0.210 |
Why?
|
| Fluid Therapy | 1 | 2004 | 66 | 0.210 |
Why?
|
| Pneumonia | 1 | 2005 | 193 | 0.200 |
Why?
|
| Insulin | 2 | 2019 | 1185 | 0.200 |
Why?
|
| Pancreatic Elastase | 2 | 2019 | 15 | 0.200 |
Why?
|
| Dietary Fiber | 1 | 2023 | 46 | 0.190 |
Why?
|
| Female | 20 | 2023 | 48702 | 0.180 |
Why?
|
| Endodermal Sinus Tumor | 1 | 2002 | 3 | 0.180 |
Why?
|
| Liver | 2 | 2023 | 1210 | 0.180 |
Why?
|
| Constipation | 2 | 2023 | 66 | 0.180 |
Why?
|
| Body Mass Index | 2 | 2018 | 811 | 0.180 |
Why?
|
| Pelvic Neoplasms | 1 | 2002 | 42 | 0.180 |
Why?
|
| Teratoma | 1 | 2002 | 58 | 0.170 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2021 | 26 | 0.170 |
Why?
|
| Powders | 1 | 2022 | 83 | 0.170 |
Why?
|
| Pancreas | 2 | 2019 | 258 | 0.170 |
Why?
|
| Societies | 1 | 2020 | 14 | 0.160 |
Why?
|
| Vitamin D | 1 | 2002 | 272 | 0.160 |
Why?
|
| Body Weight | 3 | 2013 | 449 | 0.160 |
Why?
|
| Nutritional Requirements | 2 | 2013 | 16 | 0.160 |
Why?
|
| Steatorrhea | 1 | 2019 | 2 | 0.160 |
Why?
|
| Trypsinogen | 1 | 2019 | 4 | 0.160 |
Why?
|
| Magnesium Deficiency | 1 | 2019 | 5 | 0.160 |
Why?
|
| Ectodermal Dysplasia | 1 | 2019 | 2 | 0.160 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2019 | 3 | 0.160 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2019 | 6 | 0.160 |
Why?
|
| Pancreatic Function Tests | 1 | 2019 | 7 | 0.160 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2019 | 8 | 0.160 |
Why?
|
| Rest | 1 | 2000 | 50 | 0.160 |
Why?
|
| Thiamine Deficiency | 1 | 2019 | 4 | 0.160 |
Why?
|
| Anus, Imperforate | 1 | 2019 | 11 | 0.160 |
Why?
|
| Chymotrypsin | 1 | 2019 | 28 | 0.160 |
Why?
|
| Hypokalemia | 1 | 2019 | 22 | 0.150 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2022 | 646 | 0.150 |
Why?
|
| Mitochondrial Diseases | 1 | 2019 | 12 | 0.150 |
Why?
|
| Retrospective Studies | 6 | 2021 | 10164 | 0.150 |
Why?
|
| Starvation | 1 | 2019 | 22 | 0.150 |
Why?
|
| Pancreatic Diseases | 1 | 2019 | 58 | 0.150 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2019 | 49 | 0.150 |
Why?
|
| Muscular Diseases | 1 | 2019 | 67 | 0.150 |
Why?
|
| Pain | 1 | 2002 | 414 | 0.150 |
Why?
|
| Nose | 1 | 2019 | 95 | 0.150 |
Why?
|
| Pancreatitis, Chronic | 1 | 2019 | 54 | 0.150 |
Why?
|
| Cerebral Palsy | 1 | 2019 | 96 | 0.150 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 1998 | 9 | 0.140 |
Why?
|
| Disability Evaluation | 1 | 2019 | 171 | 0.140 |
Why?
|
| Enema | 1 | 1998 | 36 | 0.140 |
Why?
|
| Physical Examination | 1 | 2019 | 144 | 0.140 |
Why?
|
| Pericarditis | 1 | 1998 | 14 | 0.140 |
Why?
|
| Cystic Fibrosis | 1 | 2019 | 119 | 0.140 |
Why?
|
| Intestinal Perforation | 1 | 1998 | 36 | 0.140 |
Why?
|
| Aminoglycosides | 1 | 2018 | 31 | 0.140 |
Why?
|
| Sodium | 1 | 2019 | 329 | 0.140 |
Why?
|
| Diet | 2 | 2019 | 460 | 0.140 |
Why?
|
| Intellectual Disability | 1 | 2019 | 195 | 0.140 |
Why?
|
| Drug Hypersensitivity | 1 | 1998 | 39 | 0.140 |
Why?
|
| Urinalysis | 1 | 2018 | 34 | 0.140 |
Why?
|
| Colitis, Ulcerative | 2 | 2022 | 800 | 0.140 |
Why?
|
| Celiac Disease | 1 | 2001 | 219 | 0.130 |
Why?
|
| Aging | 1 | 2002 | 727 | 0.130 |
Why?
|
| Osteoporosis | 1 | 1999 | 129 | 0.130 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 57 | 0.130 |
Why?
|
| World Health Organization | 1 | 2018 | 121 | 0.130 |
Why?
|
| Program Development | 1 | 2017 | 131 | 0.130 |
Why?
|
| Hypothyroidism | 1 | 2019 | 275 | 0.130 |
Why?
|
| Clostridium Infections | 1 | 2018 | 128 | 0.120 |
Why?
|
| United States | 4 | 2024 | 7622 | 0.120 |
Why?
|
| Milk Proteins | 1 | 2016 | 24 | 0.120 |
Why?
|
| Milk Hypersensitivity | 1 | 2016 | 12 | 0.120 |
Why?
|
| Esophagitis | 2 | 2006 | 40 | 0.110 |
Why?
|
| Disease Management | 1 | 2017 | 358 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2017 | 298 | 0.110 |
Why?
|
| Eosinophilia | 2 | 2006 | 87 | 0.110 |
Why?
|
| Birth Weight | 2 | 2016 | 150 | 0.100 |
Why?
|
| Interleukin-12 Receptor beta 1 Subunit | 1 | 2013 | 2 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2017 | 867 | 0.100 |
Why?
|
| Candidiasis | 1 | 2013 | 39 | 0.100 |
Why?
|
| Dietary Proteins | 1 | 2013 | 31 | 0.100 |
Why?
|
| Dietary Carbohydrates | 1 | 2013 | 39 | 0.100 |
Why?
|
| Risk Factors | 2 | 2019 | 5899 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 836 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 2 | 2013 | 1053 | 0.090 |
Why?
|
| HIV Infections | 1 | 2001 | 961 | 0.090 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2011 | 22 | 0.080 |
Why?
|
| Food | 1 | 2011 | 92 | 0.080 |
Why?
|
| Antigens | 1 | 2011 | 224 | 0.080 |
Why?
|
| Body Height | 2 | 2000 | 107 | 0.080 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 69 | 0.080 |
Why?
|
| Acidosis | 1 | 2009 | 53 | 0.070 |
Why?
|
| Drug Administration Schedule | 2 | 2018 | 829 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2009 | 239 | 0.070 |
Why?
|
| Gastrointestinal Diseases | 1 | 2009 | 149 | 0.070 |
Why?
|
| Bacterial Translocation | 1 | 2008 | 26 | 0.070 |
Why?
|
| Cattle | 2 | 2020 | 397 | 0.070 |
Why?
|
| Prevalence | 2 | 2002 | 1321 | 0.070 |
Why?
|
| Placebos | 1 | 2008 | 206 | 0.070 |
Why?
|
| Recurrence | 3 | 2013 | 1190 | 0.070 |
Why?
|
| Animals | 4 | 2020 | 28155 | 0.070 |
Why?
|
| Cross-Over Studies | 1 | 2008 | 390 | 0.060 |
Why?
|
| Age Factors | 1 | 2010 | 1906 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2001 | 1847 | 0.060 |
Why?
|
| Osmolar Concentration | 1 | 2004 | 168 | 0.050 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2004 | 76 | 0.050 |
Why?
|
| Adult | 5 | 2013 | 27918 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2008 | 1729 | 0.050 |
Why?
|
| Galactans | 1 | 2023 | 2 | 0.050 |
Why?
|
| Menarche | 1 | 2022 | 30 | 0.050 |
Why?
|
| Gastrointestinal Tract | 1 | 2004 | 195 | 0.050 |
Why?
|
| Sacrococcygeal Region | 1 | 2002 | 13 | 0.050 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2002 | 11 | 0.050 |
Why?
|
| Vitamin D Deficiency | 1 | 2002 | 107 | 0.040 |
Why?
|
| Anal Canal | 1 | 2002 | 92 | 0.040 |
Why?
|
| Seasons | 1 | 2002 | 240 | 0.040 |
Why?
|
| Perinatology | 1 | 2001 | 14 | 0.040 |
Why?
|
| Peptides | 1 | 2004 | 656 | 0.040 |
Why?
|
| Beverages | 1 | 2020 | 16 | 0.040 |
Why?
|
| Age Determination by Skeleton | 1 | 2000 | 12 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2002 | 362 | 0.040 |
Why?
|
| Milk, Human | 1 | 2020 | 50 | 0.040 |
Why?
|
| Puberty | 1 | 2000 | 54 | 0.040 |
Why?
|
| Medical Records | 1 | 2000 | 121 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2011 | 3054 | 0.040 |
Why?
|
| Absorptiometry, Photon | 1 | 2000 | 109 | 0.040 |
Why?
|
| Health Education | 1 | 2020 | 105 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2000 | 315 | 0.040 |
Why?
|
| Universities | 1 | 2020 | 150 | 0.040 |
Why?
|
| Diphosphonates | 1 | 1999 | 36 | 0.040 |
Why?
|
| Abdomen, Acute | 1 | 1998 | 21 | 0.040 |
Why?
|
| Sulfasalazine | 1 | 1998 | 33 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 1998 | 295 | 0.030 |
Why?
|
| Prednisone | 1 | 1998 | 242 | 0.030 |
Why?
|
| Bone Density | 1 | 1999 | 237 | 0.030 |
Why?
|
| North America | 1 | 2017 | 195 | 0.030 |
Why?
|
| Sex Factors | 1 | 2000 | 1105 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2018 | 657 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2020 | 621 | 0.030 |
Why?
|
| Protein Hydrolysates | 1 | 2016 | 9 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 2585 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2000 | 1713 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 2715 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2013 | 86 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 2802 | 0.020 |
Why?
|
| Seafood | 1 | 2011 | 11 | 0.020 |
Why?
|
| Eggs | 1 | 2011 | 13 | 0.020 |
Why?
|
| Antigens, Plant | 1 | 2011 | 15 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2011 | 82 | 0.020 |
Why?
|
| Esophagus | 1 | 2011 | 113 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2018 | 9099 | 0.020 |
Why?
|
| Remission Induction | 1 | 2011 | 738 | 0.020 |
Why?
|
| Biopsy | 1 | 2011 | 1175 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2006 | 237 | 0.010 |
Why?
|
| Esophagoscopy | 1 | 2004 | 91 | 0.010 |
Why?
|
| Gastroesophageal Reflux | 1 | 2004 | 121 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 1799 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 3830 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 27573 | 0.010 |
Why?
|